P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias

Richard, K., Schober, S., Rami, M., Mall, S., Merl, J., Slotta-Huspenina, J., … Krackhardt, A. (2014). P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias. Journal for ImmunoTherapy of Cancer, 2(S2). https://doi.org/10.1186/2051-1426-2-s2-p43